These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 36291080)

  • 21. Development in anticoagulant therapy.
    van Doormaal FF; Büller HR; Middeldorp S
    Crit Rev Oncol Hematol; 2008 May; 66(2):145-54. PubMed ID: 18032061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer.
    Ueyama H; Miyashita H; Takagi H; Cruz C; Burger A; Briasoulis A; Kuno T
    J Thromb Thrombolysis; 2021 Jan; 51(1):102-111. PubMed ID: 32458316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
    Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
    J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New advances in anticoagulation: is it time to forget about heparin and vitamin K antagonists? Yes].
    Blanco-Molina A
    Rev Clin Esp; 2012 Jan; 212 Suppl 1():3-7. PubMed ID: 23117646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin and anticoagulation.
    Onishi A; St Ange K; Dordick JS; Linhardt RJ
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1372-92. PubMed ID: 27100512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism.
    Riva N; Ageno W
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1035-51. PubMed ID: 27637306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants.
    Weitz JI; Jaffer IH
    Pol Arch Med Wewn; 2016 Sep; 126(9):688-696. PubMed ID: 27592622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study.
    Poli D; Antonucci E; Bertù L; Vignini E; Ruocco L; Mastroiacovo D; Paparo C; Pastori D; Testa S; Ageno W; Palareti G;
    Thromb Res; 2019 Nov; 183():28-32. PubMed ID: 31536872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New anticoagulants in the treatment of venous thromboembolism].
    Bura-Rivière A
    Rev Prat; 2013 Sep; 63(7):980-4. PubMed ID: 24167902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Anticoagulation with Novel Oral Anticoagulants an Effective Treatment for Tuberculosis Patients not Achieving a Therapeutic Range with Vitamin K Antagonists? A Systematic Review.
    Fiore M; Maraolo AE; Chiodini P; Cerchione C; Gentile I; Borgia G; Pace MC
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):105-110. PubMed ID: 28676032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of venous thromboembolism in elderly patients in the era of direct oral anticoagulants.
    Tritschler T; Castellucci LA; Van Es N; Aujesky D; Le Gal G
    Pol Arch Intern Med; 2020 Jun; 130(6):529-538. PubMed ID: 32125293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survey of current treatment practices for venous thromboembolism in patients with cystic fibrosis.
    Ratté MT; Jones AE; Witt DM; Young DC
    Pediatr Pulmonol; 2020 Jan; 55(1):149-155. PubMed ID: 31502767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
    O'Connell C; Escalante CP; Goldhaber SZ; McBane R; Connors JM; Raskob GE
    Oncologist; 2021 Jan; 26(1):e8-e16. PubMed ID: 33275319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New anticoagulants for treatment of venous thromboembolism.
    Gross PL; Weitz JI
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):380-6. PubMed ID: 18296593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.
    Imberti D; Pomero F; Benedetti R; Fenoglio L
    Intern Emerg Med; 2016 Oct; 11(7):895-900. PubMed ID: 27550399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal function and venous thromboembolic diseases.
    Janus N; Mahé I; Launay-Vacher V; Laroche JP; Deray G
    J Mal Vasc; 2016 Dec; 41(6):389-395. PubMed ID: 28029509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer.
    Walenga JM; Lyman GH
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):1-18. PubMed ID: 23849978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of venous thromboembolic disease in cancer patients].
    Farge-Bancel D; Florea L; Bosquet L; Debourdeau P
    Pathol Biol (Paris); 2008 Jun; 56(4):220-8. PubMed ID: 18394821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolism.
    Bertoletti L; Ollier E; Duvillard C; Delavenne X; Beyens MN; De Magalhaes E; Bellet F; Basset T; Mismetti P; Laporte S
    Pharmacol Res; 2017 Apr; 118():33-42. PubMed ID: 27350265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Update on the "Novel" and Direct Oral Anticoagulants, and Long-Term Anticoagulant Therapy.
    Djulbegovic M; Lee AI
    Clin Chest Med; 2018 Sep; 39(3):583-593. PubMed ID: 30122182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.